HALO fund manager activity
Halozyme Therapeutics, Inc · Nasdaq. Reported by 7 tracked fund managers in their 13F filings, Q4 2013 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ken Fisher - Fisher Asset Management | Added | 467,852 | $31,486,439 | 0.01% | Feb 9, 2026 |
| Joel Greenblatt - Gotham Asset Management | Added | 439,708 | $29,592,348 | 0.11% | Feb 17, 2026 |
| Richard Pzena - Pzena Investment Management | Added | 4,278 | $287,909 | 0.00% | Feb 6, 2026 |
| Torray Funds | Added | 38,135 | $2,566,485 | 0.37% | Jan 28, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ken Fisher - Fisher Asset Management | Added | 410,892 | $30,134,818 | 0.01% | Nov 12, 2025 |
| Joel Greenblatt - Gotham Asset Management | Added | 252,934 | $18,550,180 | 0.08% | Nov 14, 2025 |
| Richard Pzena - Pzena Investment Management | New | 4,107 | $301,207 | 0.00% | Nov 7, 2025 |
| Torray Funds | Trimmed | 38,121 | $2,795,794 | 0.38% | Oct 22, 2025 |
Newer quarters · Older quarters